Segment Information (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Reconciliation Of Segment Information To Total Consolidated Information

(In thousands)	Generics Segment		Specialty Segment		Corporate / Other(1)			Consolidated
Three Months Ended June 30, 2013
Total revenues
Third party	$	1,458,214	$	243,487	$	—		$	1,701,701
Intersegment	1,824		5,904		(7,728		)	—
Total	$	1,460,038	$	249,391	$	(7,728	)	$	1,701,701
Segment profitability	$	412,230	$	107,761	$	(211,372	)	$	308,619
Six Months Ended June 30, 2013
Total revenues
Third party	$	2,871,031	$	462,160	$	—		$	3,333,191
Intersegment	2,453		13,832		(16,285		)	—
Total	$	2,873,484	$	475,992	$	(16,285	)	$	3,333,191
Segment profitability	$	804,290	$	197,568	$	(479,392	)	$	522,466

(In thousands)	Generics Segment		Specialty Segment		Corporate / Other(1)			Consolidated
Three Months Ended June 30, 2012
Total revenues
Third party	$	1,481,120	$	206,695	$	—		$	1,687,815
Intersegment	388		9,093		(9,481		)	—
Total	$	1,481,508	$	215,788	$	(9,481	)	$	1,687,815
Segment profitability	$	407,865	$	68,682	$	(215,076	)	$	261,471
Six Months Ended June 30, 2012
Total revenues
Third party	$	2,893,596	$	377,874	$	—		$	3,271,470
Intersegment	743		23,672		(24,415		)	—
Total	$	2,894,339	$	401,546	$	(24,415	)	$	3,271,470
Segment profitability	$	819,529	$	129,140	$	(436,660	)	$	512,009

____________

⁽¹⁾  Includes certain corporate general and administrative and research and development expenses; net charges for litigation settlements; certain intercompany transactions, including eliminations; amortization of intangible assets and certain purchase accounting items; impairment charges; and other expenses not directly attributable to segments.